Medical Care
Antimicrobial Susceptibility Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 550873
- Pages: 136
- Figures: 208
- Views: 1
The global market for Antimicrobial Susceptibility Testing was estimated to be worth US$ 1085.5 million in 2023 and is forecast to a readjusted size of US$ 1848.8 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Susceptibility Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antimicrobial Susceptibility Testing by region & country, by Type, and by Application.
The Antimicrobial Susceptibility Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Susceptibility Testing.
Market Segmentation
By Company
Biomérieux
Danaher
BD
Thermo Fisher
Bio-Rad
Hi-Media
Merlin
Liofilchem
Accelerate Diagnostics
Alifax
Creative Diagnostics
Merck Group
Synbiosis
Bioanalyse
Zhuhai Dl Biotech
Segment by Type:
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing
Segment by Application
Clinical Diagnostics
Drug Discovery and Development
Epidemiology
Other Applications
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antimicrobial Susceptibility Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Antimicrobial Susceptibility Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Antimicrobial Susceptibility Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Susceptibility Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antimicrobial Susceptibility Testing by region & country, by Type, and by Application.
The Antimicrobial Susceptibility Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Susceptibility Testing.
Market Segmentation
By Company
Biomérieux
Danaher
BD
Thermo Fisher
Bio-Rad
Hi-Media
Merlin
Liofilchem
Accelerate Diagnostics
Alifax
Creative Diagnostics
Merck Group
Synbiosis
Bioanalyse
Zhuhai Dl Biotech
Segment by Type:
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing
Segment by Application
Clinical Diagnostics
Drug Discovery and Development
Epidemiology
Other Applications
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antimicrobial Susceptibility Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Antimicrobial Susceptibility Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Antimicrobial Susceptibility Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Antimicrobial Susceptibility Testing Product Introduction
1.2 Global Antimicrobial Susceptibility Testing Market Size Forecast
1.3 Antimicrobial Susceptibility Testing Market Trends & Drivers
1.3.1 Antimicrobial Susceptibility Testing Industry Trends
1.3.2 Antimicrobial Susceptibility Testing Market Drivers & Opportunity
1.3.3 Antimicrobial Susceptibility Testing Market Challenges
1.3.4 Antimicrobial Susceptibility Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antimicrobial Susceptibility Testing Players Revenue Ranking (2023)
2.2 Global Antimicrobial Susceptibility Testing Revenue by Company (2019-2024)
2.3 Key Companies Antimicrobial Susceptibility Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antimicrobial Susceptibility Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Antimicrobial Susceptibility Testing
2.6 Antimicrobial Susceptibility Testing Market Competitive Analysis
2.6.1 Antimicrobial Susceptibility Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Antimicrobial Susceptibility Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Susceptibility Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antibacterial Susceptibility Testing
3.1.2 Antifungal Susceptibility Testing
3.1.3 Antiparasitic Susceptibility Testing
3.1.4 Other Susceptibility Testing
3.2 Global Antimicrobial Susceptibility Testing Sales Value by Type
3.2.1 Global Antimicrobial Susceptibility Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antimicrobial Susceptibility Testing Sales Value, by Type (2019-2030)
3.2.3 Global Antimicrobial Susceptibility Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinical Diagnostics
4.1.2 Drug Discovery and Development
4.1.3 Epidemiology
4.1.4 Other Applications
4.2 Global Antimicrobial Susceptibility Testing Sales Value by Application
4.2.1 Global Antimicrobial Susceptibility Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antimicrobial Susceptibility Testing Sales Value, by Application (2019-2030)
4.2.3 Global Antimicrobial Susceptibility Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Antimicrobial Susceptibility Testing Sales Value by Region
5.1.1 Global Antimicrobial Susceptibility Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antimicrobial Susceptibility Testing Sales Value by Region (2019-2024)
5.1.3 Global Antimicrobial Susceptibility Testing Sales Value by Region (2025-2030)
5.1.4 Global Antimicrobial Susceptibility Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.2.2 North America Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.3.2 Europe Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.5.2 South America Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value
6.3 United States
6.3.1 United States Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.3.2 United States Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.4.2 Europe Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.5.2 China Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.6.2 Japan Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.7.2 South Korea Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.9.2 India Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biomérieux
7.1.1 Biomérieux Profile
7.1.2 Biomérieux Main Business
7.1.3 Biomérieux Antimicrobial Susceptibility Testing Products, Services and Solutions
7.1.4 Biomérieux Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Biomérieux Recent Developments
7.2 Danaher
7.2.1 Danaher Profile
7.2.2 Danaher Main Business
7.2.3 Danaher Antimicrobial Susceptibility Testing Products, Services and Solutions
7.2.4 Danaher Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Danaher Recent Developments
7.3 BD
7.3.1 BD Profile
7.3.2 BD Main Business
7.3.3 BD Antimicrobial Susceptibility Testing Products, Services and Solutions
7.3.4 BD Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Thermo Fisher Recent Developments
7.4 Thermo Fisher
7.4.1 Thermo Fisher Profile
7.4.2 Thermo Fisher Main Business
7.4.3 Thermo Fisher Antimicrobial Susceptibility Testing Products, Services and Solutions
7.4.4 Thermo Fisher Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Thermo Fisher Recent Developments
7.5 Bio-Rad
7.5.1 Bio-Rad Profile
7.5.2 Bio-Rad Main Business
7.5.3 Bio-Rad Antimicrobial Susceptibility Testing Products, Services and Solutions
7.5.4 Bio-Rad Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Bio-Rad Recent Developments
7.6 Hi-Media
7.6.1 Hi-Media Profile
7.6.2 Hi-Media Main Business
7.6.3 Hi-Media Antimicrobial Susceptibility Testing Products, Services and Solutions
7.6.4 Hi-Media Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Hi-Media Recent Developments
7.7 Merlin
7.7.1 Merlin Profile
7.7.2 Merlin Main Business
7.7.3 Merlin Antimicrobial Susceptibility Testing Products, Services and Solutions
7.7.4 Merlin Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Merlin Recent Developments
7.8 Liofilchem
7.8.1 Liofilchem Profile
7.8.2 Liofilchem Main Business
7.8.3 Liofilchem Antimicrobial Susceptibility Testing Products, Services and Solutions
7.8.4 Liofilchem Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Liofilchem Recent Developments
7.9 Accelerate Diagnostics
7.9.1 Accelerate Diagnostics Profile
7.9.2 Accelerate Diagnostics Main Business
7.9.3 Accelerate Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
7.9.4 Accelerate Diagnostics Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Accelerate Diagnostics Recent Developments
7.10 Alifax
7.10.1 Alifax Profile
7.10.2 Alifax Main Business
7.10.3 Alifax Antimicrobial Susceptibility Testing Products, Services and Solutions
7.10.4 Alifax Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Alifax Recent Developments
7.11 Creative Diagnostics
7.11.1 Creative Diagnostics Profile
7.11.2 Creative Diagnostics Main Business
7.11.3 Creative Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
7.11.4 Creative Diagnostics Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Creative Diagnostics Recent Developments
7.12 Merck Group
7.12.1 Merck Group Profile
7.12.2 Merck Group Main Business
7.12.3 Merck Group Antimicrobial Susceptibility Testing Products, Services and Solutions
7.12.4 Merck Group Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Merck Group Recent Developments
7.13 Synbiosis
7.13.1 Synbiosis Profile
7.13.2 Synbiosis Main Business
7.13.3 Synbiosis Antimicrobial Susceptibility Testing Products, Services and Solutions
7.13.4 Synbiosis Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Synbiosis Recent Developments
7.14 Bioanalyse
7.14.1 Bioanalyse Profile
7.14.2 Bioanalyse Main Business
7.14.3 Bioanalyse Antimicrobial Susceptibility Testing Products, Services and Solutions
7.14.4 Bioanalyse Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.14.5 Bioanalyse Recent Developments
7.15 Zhuhai Dl Biotech
7.15.1 Zhuhai Dl Biotech Profile
7.15.2 Zhuhai Dl Biotech Main Business
7.15.3 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Products, Services and Solutions
7.15.4 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.15.5 Zhuhai Dl Biotech Recent Developments
8 Industry Chain Analysis
8.1 Antimicrobial Susceptibility Testing Industrial Chain
8.2 Antimicrobial Susceptibility Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antimicrobial Susceptibility Testing Sales Model
8.5.2 Sales Channel
8.5.3 Antimicrobial Susceptibility Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Antimicrobial Susceptibility Testing Product Introduction
1.2 Global Antimicrobial Susceptibility Testing Market Size Forecast
1.3 Antimicrobial Susceptibility Testing Market Trends & Drivers
1.3.1 Antimicrobial Susceptibility Testing Industry Trends
1.3.2 Antimicrobial Susceptibility Testing Market Drivers & Opportunity
1.3.3 Antimicrobial Susceptibility Testing Market Challenges
1.3.4 Antimicrobial Susceptibility Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antimicrobial Susceptibility Testing Players Revenue Ranking (2023)
2.2 Global Antimicrobial Susceptibility Testing Revenue by Company (2019-2024)
2.3 Key Companies Antimicrobial Susceptibility Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antimicrobial Susceptibility Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Antimicrobial Susceptibility Testing
2.6 Antimicrobial Susceptibility Testing Market Competitive Analysis
2.6.1 Antimicrobial Susceptibility Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Antimicrobial Susceptibility Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Susceptibility Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antibacterial Susceptibility Testing
3.1.2 Antifungal Susceptibility Testing
3.1.3 Antiparasitic Susceptibility Testing
3.1.4 Other Susceptibility Testing
3.2 Global Antimicrobial Susceptibility Testing Sales Value by Type
3.2.1 Global Antimicrobial Susceptibility Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antimicrobial Susceptibility Testing Sales Value, by Type (2019-2030)
3.2.3 Global Antimicrobial Susceptibility Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinical Diagnostics
4.1.2 Drug Discovery and Development
4.1.3 Epidemiology
4.1.4 Other Applications
4.2 Global Antimicrobial Susceptibility Testing Sales Value by Application
4.2.1 Global Antimicrobial Susceptibility Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antimicrobial Susceptibility Testing Sales Value, by Application (2019-2030)
4.2.3 Global Antimicrobial Susceptibility Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Antimicrobial Susceptibility Testing Sales Value by Region
5.1.1 Global Antimicrobial Susceptibility Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antimicrobial Susceptibility Testing Sales Value by Region (2019-2024)
5.1.3 Global Antimicrobial Susceptibility Testing Sales Value by Region (2025-2030)
5.1.4 Global Antimicrobial Susceptibility Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.2.2 North America Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.3.2 Europe Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.5.2 South America Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Antimicrobial Susceptibility Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value
6.3 United States
6.3.1 United States Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.3.2 United States Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.4.2 Europe Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.5.2 China Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.6.2 Japan Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.7.2 South Korea Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antimicrobial Susceptibility Testing Sales Value, 2019-2030
6.9.2 India Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antimicrobial Susceptibility Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biomérieux
7.1.1 Biomérieux Profile
7.1.2 Biomérieux Main Business
7.1.3 Biomérieux Antimicrobial Susceptibility Testing Products, Services and Solutions
7.1.4 Biomérieux Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Biomérieux Recent Developments
7.2 Danaher
7.2.1 Danaher Profile
7.2.2 Danaher Main Business
7.2.3 Danaher Antimicrobial Susceptibility Testing Products, Services and Solutions
7.2.4 Danaher Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Danaher Recent Developments
7.3 BD
7.3.1 BD Profile
7.3.2 BD Main Business
7.3.3 BD Antimicrobial Susceptibility Testing Products, Services and Solutions
7.3.4 BD Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Thermo Fisher Recent Developments
7.4 Thermo Fisher
7.4.1 Thermo Fisher Profile
7.4.2 Thermo Fisher Main Business
7.4.3 Thermo Fisher Antimicrobial Susceptibility Testing Products, Services and Solutions
7.4.4 Thermo Fisher Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Thermo Fisher Recent Developments
7.5 Bio-Rad
7.5.1 Bio-Rad Profile
7.5.2 Bio-Rad Main Business
7.5.3 Bio-Rad Antimicrobial Susceptibility Testing Products, Services and Solutions
7.5.4 Bio-Rad Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Bio-Rad Recent Developments
7.6 Hi-Media
7.6.1 Hi-Media Profile
7.6.2 Hi-Media Main Business
7.6.3 Hi-Media Antimicrobial Susceptibility Testing Products, Services and Solutions
7.6.4 Hi-Media Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Hi-Media Recent Developments
7.7 Merlin
7.7.1 Merlin Profile
7.7.2 Merlin Main Business
7.7.3 Merlin Antimicrobial Susceptibility Testing Products, Services and Solutions
7.7.4 Merlin Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Merlin Recent Developments
7.8 Liofilchem
7.8.1 Liofilchem Profile
7.8.2 Liofilchem Main Business
7.8.3 Liofilchem Antimicrobial Susceptibility Testing Products, Services and Solutions
7.8.4 Liofilchem Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Liofilchem Recent Developments
7.9 Accelerate Diagnostics
7.9.1 Accelerate Diagnostics Profile
7.9.2 Accelerate Diagnostics Main Business
7.9.3 Accelerate Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
7.9.4 Accelerate Diagnostics Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Accelerate Diagnostics Recent Developments
7.10 Alifax
7.10.1 Alifax Profile
7.10.2 Alifax Main Business
7.10.3 Alifax Antimicrobial Susceptibility Testing Products, Services and Solutions
7.10.4 Alifax Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Alifax Recent Developments
7.11 Creative Diagnostics
7.11.1 Creative Diagnostics Profile
7.11.2 Creative Diagnostics Main Business
7.11.3 Creative Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
7.11.4 Creative Diagnostics Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Creative Diagnostics Recent Developments
7.12 Merck Group
7.12.1 Merck Group Profile
7.12.2 Merck Group Main Business
7.12.3 Merck Group Antimicrobial Susceptibility Testing Products, Services and Solutions
7.12.4 Merck Group Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Merck Group Recent Developments
7.13 Synbiosis
7.13.1 Synbiosis Profile
7.13.2 Synbiosis Main Business
7.13.3 Synbiosis Antimicrobial Susceptibility Testing Products, Services and Solutions
7.13.4 Synbiosis Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Synbiosis Recent Developments
7.14 Bioanalyse
7.14.1 Bioanalyse Profile
7.14.2 Bioanalyse Main Business
7.14.3 Bioanalyse Antimicrobial Susceptibility Testing Products, Services and Solutions
7.14.4 Bioanalyse Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.14.5 Bioanalyse Recent Developments
7.15 Zhuhai Dl Biotech
7.15.1 Zhuhai Dl Biotech Profile
7.15.2 Zhuhai Dl Biotech Main Business
7.15.3 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Products, Services and Solutions
7.15.4 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2019-2024)
7.15.5 Zhuhai Dl Biotech Recent Developments
8 Industry Chain Analysis
8.1 Antimicrobial Susceptibility Testing Industrial Chain
8.2 Antimicrobial Susceptibility Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antimicrobial Susceptibility Testing Sales Model
8.5.2 Sales Channel
8.5.3 Antimicrobial Susceptibility Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Antimicrobial Susceptibility Testing Market Trends
Table 2. Antimicrobial Susceptibility Testing Market Drivers & Opportunity
Table 3. Antimicrobial Susceptibility Testing Market Challenges
Table 4. Antimicrobial Susceptibility Testing Market Restraints
Table 5. Global Antimicrobial Susceptibility Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antimicrobial Susceptibility Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Antimicrobial Susceptibility Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Antimicrobial Susceptibility Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Antimicrobial Susceptibility Testing
Table 10. Global Antimicrobial Susceptibility Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Susceptibility Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Antimicrobial Susceptibility Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Antimicrobial Susceptibility Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Antimicrobial Susceptibility Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Antimicrobial Susceptibility Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Antimicrobial Susceptibility Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Antimicrobial Susceptibility Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Antimicrobial Susceptibility Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Antimicrobial Susceptibility Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Antimicrobial Susceptibility Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Antimicrobial Susceptibility Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Antimicrobial Susceptibility Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Antimicrobial Susceptibility Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Antimicrobial Susceptibility Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Antimicrobial Susceptibility Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Antimicrobial Susceptibility Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Biomérieux Basic Information List
Table 32. Biomérieux Description and Business Overview
Table 33. Biomérieux Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Biomérieux (2019-2024)
Table 35. Biomérieux Recent Developments
Table 36. Danaher Basic Information List
Table 37. Danaher Description and Business Overview
Table 38. Danaher Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Danaher (2019-2024)
Table 40. Danaher Recent Developments
Table 41. BD Basic Information List
Table 42. BD Description and Business Overview
Table 43. BD Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of BD (2019-2024)
Table 45. BD Recent Developments
Table 46. Thermo Fisher Basic Information List
Table 47. Thermo Fisher Description and Business Overview
Table 48. Thermo Fisher Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Thermo Fisher (2019-2024)
Table 50. Thermo Fisher Recent Developments
Table 51. Bio-Rad Basic Information List
Table 52. Bio-Rad Description and Business Overview
Table 53. Bio-Rad Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Bio-Rad (2019-2024)
Table 55. Bio-Rad Recent Developments
Table 56. Hi-Media Basic Information List
Table 57. Hi-Media Description and Business Overview
Table 58. Hi-Media Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Hi-Media (2019-2024)
Table 60. Hi-Media Recent Developments
Table 61. Merlin Basic Information List
Table 62. Merlin Description and Business Overview
Table 63. Merlin Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Merlin (2019-2024)
Table 65. Merlin Recent Developments
Table 66. Liofilchem Basic Information List
Table 67. Liofilchem Description and Business Overview
Table 68. Liofilchem Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Liofilchem (2019-2024)
Table 70. Liofilchem Recent Developments
Table 71. Accelerate Diagnostics Basic Information List
Table 72. Accelerate Diagnostics Description and Business Overview
Table 73. Accelerate Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Accelerate Diagnostics (2019-2024)
Table 75. Accelerate Diagnostics Recent Developments
Table 76. Alifax Basic Information List
Table 77. Alifax Description and Business Overview
Table 78. Alifax Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Alifax (2019-2024)
Table 80. Alifax Recent Developments
Table 81. Creative Diagnostics Basic Information List
Table 82. Creative Diagnostics Description and Business Overview
Table 83. Creative Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 84. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Creative Diagnostics (2019-2024)
Table 85. Creative Diagnostics Recent Developments
Table 86. Merck Group Basic Information List
Table 87. Merck Group Description and Business Overview
Table 88. Merck Group Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 89. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Merck Group (2019-2024)
Table 90. Merck Group Recent Developments
Table 91. Synbiosis Basic Information List
Table 92. Synbiosis Description and Business Overview
Table 93. Synbiosis Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 94. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Synbiosis (2019-2024)
Table 95. Synbiosis Recent Developments
Table 96. Bioanalyse Basic Information List
Table 97. Bioanalyse Description and Business Overview
Table 98. Bioanalyse Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 99. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Bioanalyse (2019-2024)
Table 100. Bioanalyse Recent Developments
Table 101. Zhuhai Dl Biotech Basic Information List
Table 102. Zhuhai Dl Biotech Description and Business Overview
Table 103. Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 104. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Zhuhai Dl Biotech (2019-2024)
Table 105. Zhuhai Dl Biotech Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Antimicrobial Susceptibility Testing Downstream Customers
Table 109. Antimicrobial Susceptibility Testing Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antimicrobial Susceptibility Testing Product Picture
Figure 2. Global Antimicrobial Susceptibility Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Antimicrobial Susceptibility Testing Report Years Considered
Figure 5. Global Antimicrobial Susceptibility Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antimicrobial Susceptibility Testing Revenue in 2023
Figure 7. Antimicrobial Susceptibility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Antibacterial Susceptibility Testing Picture
Figure 9. Antifungal Susceptibility Testing Picture
Figure 10. Antiparasitic Susceptibility Testing Picture
Figure 11. Other Susceptibility Testing Picture
Figure 12. Global Antimicrobial Susceptibility Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Antimicrobial Susceptibility Testing Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Clinical Diagnostics
Figure 15. Product Picture of Drug Discovery and Development
Figure 16. Product Picture of Epidemiology
Figure 17. Product Picture of Other Applications
Figure 18. Global Antimicrobial Susceptibility Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Antimicrobial Susceptibility Testing Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value (%), (2019-2030)
Figure 31. United States Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 37. China Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 39. China Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 49. India Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 51. India Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 52. Antimicrobial Susceptibility Testing Industrial Chain
Figure 53. Antimicrobial Susceptibility Testing Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Table 1. Antimicrobial Susceptibility Testing Market Trends
Table 2. Antimicrobial Susceptibility Testing Market Drivers & Opportunity
Table 3. Antimicrobial Susceptibility Testing Market Challenges
Table 4. Antimicrobial Susceptibility Testing Market Restraints
Table 5. Global Antimicrobial Susceptibility Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Antimicrobial Susceptibility Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Antimicrobial Susceptibility Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Antimicrobial Susceptibility Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Antimicrobial Susceptibility Testing
Table 10. Global Antimicrobial Susceptibility Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Susceptibility Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Antimicrobial Susceptibility Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Antimicrobial Susceptibility Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Antimicrobial Susceptibility Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Antimicrobial Susceptibility Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Antimicrobial Susceptibility Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Antimicrobial Susceptibility Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Antimicrobial Susceptibility Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Antimicrobial Susceptibility Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Antimicrobial Susceptibility Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Antimicrobial Susceptibility Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Antimicrobial Susceptibility Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Antimicrobial Susceptibility Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Antimicrobial Susceptibility Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Antimicrobial Susceptibility Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Antimicrobial Susceptibility Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Biomérieux Basic Information List
Table 32. Biomérieux Description and Business Overview
Table 33. Biomérieux Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Biomérieux (2019-2024)
Table 35. Biomérieux Recent Developments
Table 36. Danaher Basic Information List
Table 37. Danaher Description and Business Overview
Table 38. Danaher Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Danaher (2019-2024)
Table 40. Danaher Recent Developments
Table 41. BD Basic Information List
Table 42. BD Description and Business Overview
Table 43. BD Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of BD (2019-2024)
Table 45. BD Recent Developments
Table 46. Thermo Fisher Basic Information List
Table 47. Thermo Fisher Description and Business Overview
Table 48. Thermo Fisher Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Thermo Fisher (2019-2024)
Table 50. Thermo Fisher Recent Developments
Table 51. Bio-Rad Basic Information List
Table 52. Bio-Rad Description and Business Overview
Table 53. Bio-Rad Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Bio-Rad (2019-2024)
Table 55. Bio-Rad Recent Developments
Table 56. Hi-Media Basic Information List
Table 57. Hi-Media Description and Business Overview
Table 58. Hi-Media Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Hi-Media (2019-2024)
Table 60. Hi-Media Recent Developments
Table 61. Merlin Basic Information List
Table 62. Merlin Description and Business Overview
Table 63. Merlin Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Merlin (2019-2024)
Table 65. Merlin Recent Developments
Table 66. Liofilchem Basic Information List
Table 67. Liofilchem Description and Business Overview
Table 68. Liofilchem Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Liofilchem (2019-2024)
Table 70. Liofilchem Recent Developments
Table 71. Accelerate Diagnostics Basic Information List
Table 72. Accelerate Diagnostics Description and Business Overview
Table 73. Accelerate Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Accelerate Diagnostics (2019-2024)
Table 75. Accelerate Diagnostics Recent Developments
Table 76. Alifax Basic Information List
Table 77. Alifax Description and Business Overview
Table 78. Alifax Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Alifax (2019-2024)
Table 80. Alifax Recent Developments
Table 81. Creative Diagnostics Basic Information List
Table 82. Creative Diagnostics Description and Business Overview
Table 83. Creative Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 84. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Creative Diagnostics (2019-2024)
Table 85. Creative Diagnostics Recent Developments
Table 86. Merck Group Basic Information List
Table 87. Merck Group Description and Business Overview
Table 88. Merck Group Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 89. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Merck Group (2019-2024)
Table 90. Merck Group Recent Developments
Table 91. Synbiosis Basic Information List
Table 92. Synbiosis Description and Business Overview
Table 93. Synbiosis Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 94. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Synbiosis (2019-2024)
Table 95. Synbiosis Recent Developments
Table 96. Bioanalyse Basic Information List
Table 97. Bioanalyse Description and Business Overview
Table 98. Bioanalyse Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 99. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Bioanalyse (2019-2024)
Table 100. Bioanalyse Recent Developments
Table 101. Zhuhai Dl Biotech Basic Information List
Table 102. Zhuhai Dl Biotech Description and Business Overview
Table 103. Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Products, Services and Solutions
Table 104. Revenue (US$ Million) in Antimicrobial Susceptibility Testing Business of Zhuhai Dl Biotech (2019-2024)
Table 105. Zhuhai Dl Biotech Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Antimicrobial Susceptibility Testing Downstream Customers
Table 109. Antimicrobial Susceptibility Testing Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antimicrobial Susceptibility Testing Product Picture
Figure 2. Global Antimicrobial Susceptibility Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Antimicrobial Susceptibility Testing Report Years Considered
Figure 5. Global Antimicrobial Susceptibility Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Antimicrobial Susceptibility Testing Revenue in 2023
Figure 7. Antimicrobial Susceptibility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Antibacterial Susceptibility Testing Picture
Figure 9. Antifungal Susceptibility Testing Picture
Figure 10. Antiparasitic Susceptibility Testing Picture
Figure 11. Other Susceptibility Testing Picture
Figure 12. Global Antimicrobial Susceptibility Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Antimicrobial Susceptibility Testing Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Clinical Diagnostics
Figure 15. Product Picture of Drug Discovery and Development
Figure 16. Product Picture of Epidemiology
Figure 17. Product Picture of Other Applications
Figure 18. Global Antimicrobial Susceptibility Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Antimicrobial Susceptibility Testing Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Antimicrobial Susceptibility Testing Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Antimicrobial Susceptibility Testing Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Antimicrobial Susceptibility Testing Sales Value (%), (2019-2030)
Figure 31. United States Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 37. China Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 39. China Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 49. India Antimicrobial Susceptibility Testing Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Antimicrobial Susceptibility Testing Sales Value by Type (%), 2023 VS 2030
Figure 51. India Antimicrobial Susceptibility Testing Sales Value by Application (%), 2023 VS 2030
Figure 52. Antimicrobial Susceptibility Testing Industrial Chain
Figure 53. Antimicrobial Susceptibility Testing Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232